Sun Pharma to acquire 16.33% in US-based Surgimatix for $3-M

Publicly listed Sun Pharmaceutical Industries is to acquire a 16.33% stake in Illinois (USA)-headquartered Surgimatix Inc, for USD 3.05 million (INR 25 crore).Surgimatix is engaged in developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries. It is yet to commence its commercial operations.